Pamela Garzone - Anixa Biosciences Chief Officer

ANIX Stock  USD 3.15  0.08  2.61%   

Insider

Pamela Garzone is Chief Officer of Anixa Biosciences
Age 70
Phone408 708 9808
Webhttps://www.anixa.com

Anixa Biosciences Management Efficiency

The company has return on total asset (ROA) of (0.367) % which means that it has lost $0.367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.601) %, meaning that it created substantial loss on money invested by shareholders. Anixa Biosciences' management efficiency ratios could be used to measure how well Anixa Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.
Anixa Biosciences currently holds 232 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Anixa Biosciences has a current ratio of 21.57, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Anixa Biosciences' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Erick MDAcrivon Therapeutics, Common
67
Trishna MDIn8bio Inc
45
BSc FRCPathINmune Bio
59
William HoIn8bio Inc
45
Thomas SchwerzmannMolecular Partners AG
N/A
Brian MDRezolute
50
Dr IIICue Biopharma
49
Claudine BruckAnnovis Bio
65
David MackPmv Pharmaceuticals
63
Robyn SweinhartRezolute
N/A
Ori WarshavskyPolyPid
47
Dikla AkselbradPolyPid
52
LLM JDRezolute
63
Steven AlmoCue Biopharma
64
Jesper OlsenAcrivon Therapeutics, Common
N/A
Man MBAAdagene
48
Timothy PigotAerovate Therapeutics
53
Crystal MercadoAcrivon Therapeutics, Common
N/A
Michael AlleyAN2 Therapeutics
N/A
Hunter MDAerovate Therapeutics
59
Reid McCarthyAnnovis Bio
66
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Anixa Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. Anixa Biosciences (ANIX) is traded on NASDAQ Exchange in USA. It is located in 3150 Almaden Expressway, San Jose, CA, United States, 95118 and employs 5 people. Anixa Biosciences is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Anixa Biosciences Leadership Team

Elected by the shareholders, the Anixa Biosciences' board of directors comprises two types of representatives: Anixa Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anixa. The board's role is to monitor Anixa Biosciences' management team and ensure that shareholders' interests are well served. Anixa Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anixa Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Amit Kumar, Chairman of the Board and Presidentident, CEO
John Roop, Senior Engineering
Pamela Garzone, Chief Officer
Thomas Schlumpberger, Ex Diagnostics

Anixa Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Anixa Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.